MedPath

Observational study for residual tumors in low-risk and intermediate-risk neuroblastomas

Not Applicable
Recruiting
Conditions
euroblastoma
Registration Number
JPRN-UMIN000050009
Lead Sponsor
Japan Children's Cancer Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1) Cases of multiple cancers 2) Pregnant women, women who may be pregnant, or women who are breast-feeding 3) Patients with psychosis or psychiatric symptoms that make it difficult for them to participate in the study 4) Cases with other illnesses, severe complications or severe malformations for which are inappropriate to participate in the study 5) Patients with INRG stage MS younger than 18 months of age who are classified as intermediate risk by COG risk classification and subsequently determined to have an abnormal 11q

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath